日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical trial success rate in lymphoma: fate of trials and agents from 2000 to 2019

淋巴瘤临床试验成功率:2000年至2019年试验和药物的命运

Luo, Zhiping; Li, Meng; Primeaux, Brian C; Shah, Rahul; Lin, Ruitao; Iyer, Swaminathan P; Nastoupil, Loretta J; Green, Michael R; Westin, Jason R; Flowers, Christopher R; Chihara, Dai

Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy

接受布伦妥昔单抗和波拉妥珠单抗治疗后出现的胃肠道不良事件

Kuang, Andrew G; Shatila, Malek; Shah, Jay S; Mittal, Nitish; Naz, Sidra; Ebinama, Ugochi; Iyer, Swaminathan P; Strati, Paolo; Shafi, Mehnaz A; Thomas, Anusha S; Zhang, Hao Chi; Wang, Yinghong

A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma

一种用于预测复发/难治性淋巴瘤患者接受 CAR-T 细胞治疗后严重免疫相关不良事件的循环蛋白特征

Irajizad, Ehsan; Fahrmann, Johannes F; Katayama, Hiroyuki; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Locke, Frederick L; Davila, Marco; Flowers, Christopher R; Shpall, Elizabeth; Neelapu, Sattva S; Hanash, Samir; Westin, Jason; Jain, Michael D; John, Teny M; Saini, Neeraj Y

A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma

一个源自患者的异种移植模型库,用于捕捉大B细胞淋巴瘤的临床和分子异质性

Yang, Haopeng; Arita, Kotaro; Bowman, Kevin; Chihara, Dai; Henderson, Jared; Rost, Griffin; Rojas, Estela; Parsons, Sydney; Lakra, Priya; Abedin, Aneela; Neelapu, Sattva S; Strati, Paolo; Nastoupil, Loretta J; Fayad, Luis; Iyer, Swaminathan P; Rodriguez, Alma; Hagemeister, Frederick B; Malpica, Luis; Lee, Hun Ju; Hilton, Laura; Scott, David W; Davis, Richard Eric; Flowers, Christopher R; Westin, Jason R; Inghirami, Giorgio; Vega, Francisco; Green, Michael R

Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study

CTX130(一种靶向CD70的同种异体CRISPR-Cas9基因编辑CAR T细胞疗法)在复发或难治性T细胞恶性肿瘤患者中的安全性和活性(COBALT-LYM):一项单臂、开放标签、1期剂量递增研究

Iyer, Swaminathan P; Sica, R Alejandro; Ho, P Joy; Prica, Anca; Zain, Jasmine; Foss, Francine M; Hu, Boyu; Beitinjaneh, Amer; Weng, Wen-Kai; Kim, Youn H; Khodadoust, Michael S; Huen, Auris O; Williams, Leah M; Ma, Anna; Huang, Elaine; Ganpule, Avanti; Nagar, Shashwat Deepali; Sripakdeevong, Parin; Cullingford, Erika L; Karnik, Sushant; Dequeant, Mary-Lee; Patel, Janki N; He, Xinyi Shirley; Li, Ziliang; He, Qiuling Ally; Mendonez, Joy H; Keegan, Alissa; Horwitz, Steven M

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

抗生素引起的肠道微生物群代谢输出下降与CAR-T细胞疗法的临床反应相关

Prasad, Rishika; Rehman, Abdur; Rehman, Lubna; Darbaniyan, Faezeh; Blumenberg, Viktoria; Schubert, Maria-Luisa; Mor, Uria; Zamir, Eli; Schmidt, Sabine; Hayase, Tomo; Chang, Chia-Chi; McDaniel, Lauren; Flores, Ivonne; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Jain, Preetesh; Nastoupil, Loretta J; Westin, Jason; Arora, Reetakshi; Turner, Joel; Khawaja, Fareed; Wu, Ranran; Dennison, Jennifer B; Menges, Meghan; Hidalgo-Vargas, Melanie; Reid, Kayla; Davila, Marco L; Dreger, Peter; Korell, Felix; Schmitt, Anita; Tanner, Mark R; Champlin, Richard E; Flowers, Christopher R; Shpall, Elizabeth J; Hanash, Samir; Neelapu, Sattva S; Schmitt, Michael; Subklewe, Marion; Francois-Fahrmann, Johannes; Stein-Thoeringer, C K; Elinav, Eran; Jain, Michael D; Hayase, Eiko; Jenq, Robert R; Saini, Neeraj Y

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

COVID-19、噬血细胞性淋巴组织细胞增生症和CAR-T疗法中的细胞因子风暴

Long, James P; Prakash, Rishab; Edelkamp, Paul Jr; Knafl, Mark; Lionel, Anath C; Nair, Ranjit; Ahmed, Sairah; Strati, Paolo; Castillo, Luis E Malpica; Al-Zaki, Ajlan; Chien, Kelly; Chihara, Dai; Westin, Jason; Khawaja, Fareed; Nastoupil, Loretta J; Mulanovich, Victor; Futreal, Andrew; Woodman, Scott E; Daver, Naval G; Flowers, Christopher R; Neelapu, Sattva; Manzano, Joanna-Grace; Iyer, Swaminathan P

Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas

伊布替尼联合纳武利尤单抗治疗复发性中枢神经系统淋巴瘤患者的二期临床试验

Chihara, Dai; Steiner, Raphael E; Nair, Ranjit; Feng, Lei; Ahmed, Sairah; Strati, Paolo; Malpica, Luis; Griffith, Donna P; Mathew, Shivon A; Montinez, Wirt; Masand, Gita; Samaniego, Felipe; Rodriguez, Maria A; Hagemeister, Fredrick B; Fayad, Luis E; Iyer, Swaminathan P; Nastoupil, Loretta J; Neelapu, Sattva S; Flowers, Christopher R; Westin, Jason R

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma

ECHELON-2试验中,PET4反应与CD30+外周T细胞淋巴瘤患者BV-CHP方案与CHOP方案疗效的相关性

Iyer, Swaminathan; Mehta-Shah, Neha; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob H; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Alpdogan, Onder; Feldman, Tatyana A; Camus, Vincent; Gritti, Giuseppe; Zinzani, Pier Luigi; Belada, David; Mayer, Jiri; Choi, Ilseung; Cheong, June-Won; Rustia, Evelyn; Fenton, Keenan; Fanale, Michelle; Savage, Kerry J; Horwitz, Steven M

The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma

OHI 指数可预测淋巴瘤患者因器官功能障碍导致的早期死亡率以及依托泊苷治疗的生存获益。

Zoref-Lorenz, Adi; Murakami, Jun; Gurion, Ronit; Iyer, Swaminathan P; Abadi, Uri; Cohen, Inbar; Goyal, Gaurav; Mohamed, Shehab; Nikiforow, Sarah; Natour, Abd El Haleem; Weinstein, Shiri; Yacobovich, Joanne; Cho, Hae Lin; Raanani, Pia; Nagler, Arnon; Berliner, Nancy; Daver, Naval; Itchaki, Gilad; Izraeli, Shai; Ellis, Martin; Jordan, Michael B